DCF Advisers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.16M | Buy |
6,625
+375
| +6% | +$292K | 2.39% | 10 |
|
|
2025
Q1 | $5.16M | Sell |
6,250
-750
| -11% | -$619K | 2.47% | 9 |
|
|
2024
Q4 | $5.4M | Hold |
7,000
| – | – | 2.61% | 11 |
|
|
2024
Q3 | $6.2M | Hold |
7,000
| – | – | 2.48% | 8 |
|
|
2024
Q2 | $6.34M | Hold |
7,000
| – | – | 3.26% | 6 |
|
|
2024
Q1 | $5.45M | Hold |
7,000
| – | – | 2.68% | 8 |
|
|
2023
Q4 | $4.08M | Sell |
7,000
-500
| -7% | -$291K | 2.21% | 13 |
|
|
2023
Q3 | $4.03M | Hold |
7,500
| – | – | 2.19% | 11 |
|
|
2023
Q2 | $3.52M | Sell |
7,500
-750
| -9% | -$352K | 1.86% | 15 |
|
|
2023
Q1 | $2.83M | Hold |
8,250
| – | – | 1.73% | 16 |
|
|
2022
Q4 | $3.02M | Hold |
8,250
| – | – | 2.04% | 15 |
|
|
2022
Q3 | $2.67M | Hold |
8,250
| – | – | 1.72% | 18 |
|
|
2022
Q2 | $2.68M | Sell |
8,250
-2,100
| -20% | -$681K | 1.59% | 18 |
|
|
2022
Q1 | $2.96M | Sell |
10,350
-900
| -8% | -$258K | 1.3% | 19 |
|
|
2021
Q4 | $3.11M | Hold |
11,250
| – | – | 1.26% | 20 |
|
|
2021
Q3 | $2.6M | Hold |
11,250
| – | – | 1.15% | 23 |
|
|
2021
Q2 | $2.58M | Hold |
11,250
| – | – | 0.91% | 25 |
|
|
2021
Q1 | $2.1M | Buy |
11,250
+5,250
| +88% | +$981K | 0.91% | 25 |
|
|
2020
Q4 | $1.01M | Buy |
+6,000
| New | +$1.01M | 0.42% | 40 |
|